Steminent Biotherapeutics (ROCO:7729) 3-Year EBITDA Growth Rate : 7.40% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics 3-Year EBITDA Growth Rate?

Steminent Biotherapeutics's EBITDA per Share for the six months ended in Dec. 2024 was NT$-1.17.

During the past 3 years, the average EBITDA Per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Steminent Biotherapeutics was 7.40% per year. The lowest was -48.30% per year. And the median was -20.45% per year.

Competitive Comparison of Steminent Biotherapeutics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Steminent Biotherapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steminent Biotherapeutics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Steminent Biotherapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Steminent Biotherapeutics (ROCO:7729) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Steminent Biotherapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Steminent Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445

Website

http://www.steminent.com

Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines